Carbohydrate antigen 19-9 is a prognostic and predictive biomarker in patients with advanced pancreatic cancer who receive gemcitabine-containing chemotherapy
出版年份 2012 全文链接
标题
Carbohydrate antigen 19-9 is a prognostic and predictive biomarker in patients with advanced pancreatic cancer who receive gemcitabine-containing chemotherapy
作者
关键词
-
出版物
CANCER
Volume 119, Issue 2, Pages 285-292
出版商
Wiley
发表日期
2012-07-12
DOI
10.1002/cncr.27734
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Gemcitabine Plusnab-Paclitaxel Is an Active Regimen in Patients With Advanced Pancreatic Cancer: A Phase I/II Trial
- (2011) Daniel D. Von Hoff et al. JOURNAL OF CLINICAL ONCOLOGY
- Current Treatment Options for Pancreatic Carcinoma
- (2011) Emily Castellanos et al. Current Oncology Reports
- CA19-9 as a predictor of tumor response and survival in patients with advanced pancreatic cancer treated with gemcitabine based chemotherapy
- (2010) Nazik HAMMAD et al. Asia-Pacific Journal of Clinical Oncology
- A phase 2 trial of gemcitabine, 5-fluorouracil, and radiation therapy in locally advanced nonmetastatic pancreatic adenocarcinoma
- (2010) Harvey J. Mamon et al. CANCER
- A phase I study of the biomodulation of capecitabine by docetaxel and gemcitabine (mGTX) in previously untreated patients with metastatic adenocarcinoma of the pancreas
- (2010) Marisa E. Hill et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Phase II study of S-1 in patients with gemcitabine-resistant advanced pancreatic cancer
- (2010) Kentaro Sudo et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Phase II Trial of Gemcitabine, Irinotecan, and Celecoxib in Patients With Advanced Pancreatic Cancer
- (2010) Allan Lipton et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303)
- (2010) Hedy Lee Kindler et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Study Comparing Gemcitabine Plus Cetuximab Versus Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma: Southwest Oncology Group–Directed Intergroup Trial S0205
- (2010) Philip A. Philip et al. JOURNAL OF CLINICAL ONCOLOGY
- CA 19-9 as a biomarker in advanced pancreatic cancer patients randomised to gemcitabine plus axitinib or gemcitabine alone
- (2009) H S Wasan et al. BRITISH JOURNAL OF CANCER
- Cancer Statistics, 2009
- (2009) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Carbohydrate antigen 19-9 change during chemotherapy for advanced pancreatic adenocarcinoma
- (2009) Michele Reni et al. CANCER
- Phase III Randomized Comparison of Gemcitabine Versus Gemcitabine Plus Capecitabine in Patients With Advanced Pancreatic Cancer
- (2009) David Cunningham et al. JOURNAL OF CLINICAL ONCOLOGY
- Full-Dose Gemcitabine With Concurrent Radiation Therapy in Patients With Nonmetastatic Pancreatic Cancer: A Multicenter Phase II Trial
- (2008) William Small et al. JOURNAL OF CLINICAL ONCOLOGY
- CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial
- (2008) Viviane Hess et al. LANCET ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now